Where does Koji Yasuda work?

Koji Yasuda is プリンシパル at Fast Track Initiative and Board director at SONIRE Therapeutics.

What does Koji Yasuda invest in?

Koji Yasuda invests in Biotech.

Where did Koji Yasuda go to school?

Koji Yasuda studied at Harvard University (PhD, Biological Sciences); Cornell University (BS, DVM).

Koji Yasuda

Investor

プリンシパル at Fast Track Initiative · Board director at SONIRE Therapeutics

Greater Stockholm Metropolitan Area

About

Koji Yasuda earned a Doctor of Veterinary Medicine from Cornell University and a PhD in Computational Biology from Harvard University, conducting his doctoral research at the Broad Institute of MIT and Harvard, followed by a postdoctoral fellowship at Harvard. He was a founding member of Kintai Therapeutics (later Senda Biosciences), a biotech company from Flagship Pioneering, where his doctoral research formed the basis of the company's intellectual property. He subsequently worked at Takeda in Boston, leading clinical biomarker strategy for programs including Fazirsiran and modakafusp alfa, and at Pfizer, where he developed clinical biomarker strategies for targeted therapies.

Contact· self-published, not guessed

k•••@fasttrackinitiative.comreveal

Invests in

Biotech

Board director at SONIRE Therapeutics

Intro paths

→

In turn, Koji can intro founders to SONIRE Therapeutics's investors below.

SONIRE Therapeutics's investors · 1

Fast Track InitiativeTokyo · $1.2M – $184M checks · since 2026

Experience

Fast Track InitiativePrincipalcurrent2023 — presentCambridge, MA
Fast Track InitiativeConsultant2022 — 2023
PfizerAssociate Director, Translational Lead (Oncology)2021 — 2023Greater Boston Area
TakedaClinical Biomarker Lead (Oncology and Gastroenterology)2020 — 2021Cambridge, MA
Kintai TherapeuticsAssociate Director2020Cambridge, MA
Kintai TherapeuticsPrincipal Scientist2018 — 2020Cambridge, MA
Kintai TherapeuticsSenior Scientist2018Cambridge, MA
Flagship PioneeringSenior Scientist at VL45 (Kintai Therapeutics)2017 — 2018Cambridge, MA
Broad Institute of MIT and HarvardDoctoral Researcher2013 — 2017Cambridge, Massachusetts, United States
Harvard Medical SchoolVeterinary Pathology Resident New England Primate Research Center2011 — 2013Southborough, Massachusetts, United States
Stanford University Graduate School of BusinessInaugural Summer Institute of Entrepreneurship (Now known as Standford Ignite)2007Palo Alto, California, United States

Skills & more

Languages English · Japanese

From Koji's professional profile.

Colleagues at Fast Track Initiative

Natalie Roy D’Amore

Investor at Fast Track Initiative

Frequently asked questions

Who is Koji Yasuda?: Koji Yasuda earned a Doctor of Veterinary Medicine from Cornell University and a PhD in Computational Biology from Harvard University, conducting his doctoral research at the Broad Institute of MIT and Harvard, followed by a postdoctoral fellowship at Harvard. He was a founding member of Kintai Therapeutics (later Senda Biosciences), a biotech company from Flagship Pioneering, where his doctoral research formed the basis of the company's intellectual property. He subsequently worked at Takeda in Boston, leading clinical biomarker strategy for programs including Fazirsiran and modakafusp alfa, and at Pfizer, where he developed clinical biomarker strategies for targeted therapies.
Where does Koji Yasuda work?: Koji Yasuda is プリンシパル at Fast Track Initiative and Board director at SONIRE Therapeutics.
What does Koji Yasuda invest in?: Koji Yasuda invests in Biotech.
Where did Koji Yasuda go to school?: Koji Yasuda studied at Harvard University (PhD, Biological Sciences); Cornell University (BS, DVM).